{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:47:10Z","timestamp":1794491230240,"version":"4.9.1"},"reference-count":49,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,21]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Deleterious germ line RUNX1 variants cause the autosomal dominant familial platelet disorder with associated myeloid malignancy (FPDMM), characterized by thrombocytopenia, platelet dysfunction, and a predisposition to hematologic malignancies (HMs). We launched a FPDMM natural history study and, from January 2019 to December 2021, enrolled 214 participants, including 111 patients with 39 different RUNX1 variants from 45 unrelated families. Seventy of 77 patients had thrombocytopenia, 18 of 18 had abnormal platelet aggregometry, 16 of 35 had decreased platelet dense granules, and 28 of 55 had abnormal bleeding scores. Nonmalignant bone marrows showed increased numbers of megakaryocytes in 12 of 55 patients, dysmegakaryopoiesis in 42 of 55, and reduced cellularity for age in 30 of 55 adult and 17 of 21 pediatric cases. Of 111 patients, 19 were diagnosed with HMs, including myelodysplastic syndrome, acute myeloid leukemia, chronic myelomonocytic leukemia, acute lymphoblastic leukemia, and smoldering myeloma. Of those 19, 18 were relapsed or refractory to upfront therapy and referred for stem cell transplantation. In addition, 28 of 45 families had at least 1 member with HM. Moreover, 42 of 45 patients had allergic symptoms, and 24 of 30 had gastrointestinal (GI) symptoms. Our results highlight the importance of a multidisciplinary approach, early malignancy detection, and wider awareness of inherited disorders. This actively accruing, longitudinal study will genotype and phenotype more patients with FPDMM, which may lead to a better understanding of the disease pathogenesis and clinical course, which may then inform preventive and therapeutic interventions. This trial was registered at www.clinicaltrials.gov as #NCT03854318.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2023019746","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T16:55:06Z","timestamp":1695401706000},"page":"2146-2158","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":53,"title":["Natural history study of patients with familial platelet disorder with associated myeloid malignancy"],"prefix":"10.1182","volume":"142","author":[{"given":"Lea","family":"Cunningham","sequence":"first","affiliation":[{"name":"1Oncogenesis and Development Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD"},{"name":"2Immune Deficiency Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8294-5961","authenticated-orcid":false,"given":"Matthew","family":"Merguerian","sequence":"additional","affiliation":[{"name":"1Oncogenesis and Development Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD"},{"name":"3Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R.","family":"Calvo","sequence":"additional","affiliation":[{"name":"4Department of Laboratory Medicine, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joie","family":"Davis","sequence":"additional","affiliation":[{"name":"1Oncogenesis and Development Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0146-1162","authenticated-orcid":false,"given":"Natalie T.","family":"Deuitch","sequence":"additional","affiliation":[{"name":"1Oncogenesis and Development Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Dulau-Florea","sequence":"additional","affiliation":[{"name":"4Department of Laboratory Medicine, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Patel","sequence":"additional","affiliation":[{"name":"4Department of Laboratory Medicine, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yu","sequence":"additional","affiliation":[{"name":"1Oncogenesis and Development Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8189-7769","authenticated-orcid":false,"given":"Keith","family":"Sacco","sequence":"additional","affiliation":[{"name":"5Laboratory of Allergic Disease, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumona","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"6Digestive Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Passi","sequence":"additional","affiliation":[{"name":"6Digestive Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neval","family":"Ozkaya","sequence":"additional","affiliation":[{"name":"7Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4273-1139","authenticated-orcid":false,"given":"Seila","family":"De Leon","sequence":"additional","affiliation":[{"name":"4Department of Laboratory Medicine, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Chong","sequence":"additional","affiliation":[{"name":"1Oncogenesis and Development Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Craft","sequence":"additional","affiliation":[{"name":"1Oncogenesis and Development Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Diemer","sequence":"additional","affiliation":[{"name":"1Oncogenesis and Development Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Bresciani","sequence":"additional","affiliation":[{"name":"1Oncogenesis and Development Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"8Office of Clinical Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Andrews","sequence":"additional","affiliation":[{"name":"1Oncogenesis and Development Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD"},{"name":"2Immune Deficiency Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen","family":"Park","sequence":"additional","affiliation":[{"name":"8Office of Clinical Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Londa","family":"Hathaway","sequence":"additional","affiliation":[{"name":"9Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1918-4324","authenticated-orcid":false,"given":"Edward W.","family":"Cowen","sequence":"additional","affiliation":[{"name":"9Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2643-6289","authenticated-orcid":false,"given":"Theo","family":"Heller","sequence":"additional","affiliation":[{"name":"10Translational Hepatology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Ryan","sequence":"additional","affiliation":[{"name":"11Laboratory of Asthma and Lung Inflammation, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7352-6412","authenticated-orcid":false,"given":"Amisha","family":"Barochia","sequence":"additional","affiliation":[{"name":"11Laboratory of Asthma and Lung Inflammation, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khanh","family":"Nghiem","sequence":"additional","affiliation":[{"name":"4Department of Laboratory Medicine, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Niemela","sequence":"additional","affiliation":[{"name":"4Department of Laboratory Medicine, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Rosenzweig","sequence":"additional","affiliation":[{"name":"4Department of Laboratory Medicine, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0885-8568","authenticated-orcid":false,"given":"David J.","family":"Young","sequence":"additional","affiliation":[{"name":"12Laboratory of Molecular Hematopoiesis, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela A.","family":"Frischmeyer-Guerrerio","sequence":"additional","affiliation":[{"name":"5Laboratory of Allergic Disease, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Braylan","sequence":"additional","affiliation":[{"name":"4Department of Laboratory Medicine, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6779-025X","authenticated-orcid":false,"given":"Paul P.","family":"Liu","sequence":"additional","affiliation":[{"name":"1Oncogenesis and Development Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2023122116270407600_bib1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4161\/cc.3.6.951","article-title":"Runx1\/AML-1 ranks as a master regulator of adult hematopoiesis","volume":"3","author":"Ichikawa","year":"2004","journal-title":"Cell Cycle"},{"issue":"23","key":"2023122116270407600_bib2","doi-asserted-by":"crossref","first-page":"10431","DOI":"10.1073\/pnas.88.23.10431","article-title":"t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1","volume":"88","author":"Miyoshi","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"2023122116270407600_bib3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"11","key":"2023122116270407600_bib4","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"15","key":"2023122116270407600_bib5","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","article-title":"Role of RUNX1 in hematological malignancies","volume":"129","author":"Sood","year":"2017","journal-title":"Blood"},{"key":"2023122116270407600_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fcell.2017.00111","article-title":"RUNX1 mutations in inherited and sporadic leukemia","volume":"5","author":"Bellissimo","year":"2017","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2023122116270407600_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.2019000937","article-title":"Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)","volume":"136","author":"Brown","year":"2020","journal-title":"Blood"},{"issue":"6","key":"2023122116270407600_bib8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/bloodadvances.2019000901","article-title":"RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML","volume":"4","author":"Brown","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"2023122116270407600_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1182\/blood.V65.3.557.557","article-title":"Studies of a familial platelet disorder","volume":"65","author":"Dowton","year":"1985","journal-title":"Blood"},{"issue":"7","key":"2023122116270407600_bib10","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/blood.V92.7.2600","article-title":"Evidence for genetic homogeneity in a familial platelet disorder with predisposition to acute myelogenous leukemia (FPD\/AML)","volume":"92","author":"Arepally","year":"1998","journal-title":"Blood"},{"issue":"2","key":"2023122116270407600_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet"},{"issue":"4","key":"2023122116270407600_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng1268","article-title":"A\u00a0putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis","volume":"35","author":"Helms","year":"2003","journal-title":"Nat Genet"},{"issue":"4","key":"2023122116270407600_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ng1267","article-title":"An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis","volume":"35","author":"Tokuhiro","year":"2003","journal-title":"Nat Genet"},{"issue":"07","key":"2023122116270407600_bib14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4236\/ijcm.2012.37110","article-title":"Hereditary leukemia due to rare RUNX1c splice variant (L472X) presents with eczematous phenotype","volume":"03","author":"Sorrell","year":"2012","journal-title":"Int J Clin Med"},{"issue":"4","key":"2023122116270407600_bib15","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/sj.emboj.7601568","article-title":"Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles","volume":"26","author":"Matheny","year":"2007","journal-title":"EMBO J"},{"issue":"2","key":"2023122116270407600_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.seminhematol.2017.04.006","article-title":"RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM)","volume":"54","author":"Schlegelberger","year":"2017","journal-title":"Semin Hematol"},{"issue":"15","key":"2023122116270407600_bib17","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1158\/1078-0432.CCR-14-2203","article-title":"Biological activities of RUNX1 mutants predict secondary acute leukemia transformation from chronic myelomonocytic leukemia and myelodysplastic syndromes","volume":"21","author":"Tsai","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2023122116270407600_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1042819031000139611","article-title":"Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia","volume":"45","author":"Ganly","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2023122116270407600_bib19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/09537104.2013.818636","article-title":"Development of hairy cell leukemia in familial platelet disorder with predisposition to acute myeloid leukemia","volume":"25","author":"Toya","year":"2014","journal-title":"Platelets"},{"issue":"1","key":"2023122116270407600_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/08880018.2020.1814463","article-title":"Distinctive phenotypes in two children with novel germline RUNX1mutations \u2013 one with myeloid malignancy and increased fetal hemoglobin","volume":"38","author":"Bagla","year":"2021","journal-title":"Pediatr Hematol Oncol"},{"issue":"16","key":"2023122116270407600_bib21","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1182\/bloodadvances.2021004653","article-title":"B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations","volume":"5","author":"Six","year":"2021","journal-title":"Blood Adv"},{"issue":"21","key":"2023122116270407600_bib22","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1182\/blood.2019003357","article-title":"High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML","volume":"135","author":"Simon","year":"2020","journal-title":"Blood"},{"issue":"5","key":"2023122116270407600_bib23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/bjh.15990","article-title":"Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies","volume":"186","author":"Duarte","year":"2019","journal-title":"Br J Haematol"},{"issue":"2","key":"2023122116270407600_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/leu.2017.239","article-title":"Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AML","volume":"32","author":"Stengel","year":"2018","journal-title":"Leukemia"},{"issue":"22","key":"2023122116270407600_bib25","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1182\/blood-2008-07-168260","article-title":"High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder","volume":"113","author":"Preudhomme","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2023122116270407600_bib26","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41467-021-21588-4","article-title":"Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome","volume":"12","author":"Kennedy","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"2023122116270407600_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.2010.08212.x","article-title":"Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study","volume":"150","author":"Alter","year":"2010","journal-title":"Br J Haematol"},{"issue":"20","key":"2023122116270407600_bib28","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/bloodadvances.2019000644","article-title":"ClinGen myeloid malignancy variant curation expert panel recommendations for germline RUNX1\u00a0variants","volume":"3","author":"Luo","year":"2019","journal-title":"Blood Adv"},{"issue":"7","key":"2023122116270407600_bib29","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/jth.14454","article-title":"Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders","volume":"17","author":"Adler","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2023122116270407600_bib30","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/jth.15263","article-title":"The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: communication from the ISTH SSC Subcommittee on Platelet Physiology","volume":"19","author":"Gresele","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"2023122116270407600_bib31","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3324\/haematol.2018.188904","article-title":"Downregulation of TREM-like transcript-1 and collagen receptor \u03b12 subunit, two novel RUNX1-targets, contributes to platelet dysfunction in familial platelet disorder with predisposition to acute myelogenous leukemia","volume":"104","author":"Glembotsky","year":"2019","journal-title":"Haematologica"},{"issue":"49","key":"2023122116270407600_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13023-016-0432-0","article-title":"Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders","volume":"11","author":"Latger-Cannard","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2023122116270407600_bib33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/jth.12550","article-title":"Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets","volume":"12","author":"Glembotsky","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"2023122116270407600_bib34","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/09537104.2018.1476682","article-title":"Diagnostic laboratory standardization and validation of platelet transmission electron microscopy","volume":"29","author":"Chen","year":"2018","journal-title":"Platelets"},{"issue":"4","key":"2023122116270407600_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/1093526618822108","article-title":"Bone marrow morphology associated with germline RUNX1 mutations in patients with familial platelet disorder with associated myeloid malignancy","volume":"22","author":"Chisholm","year":"2019","journal-title":"Pediatr Dev Pathol"},{"issue":"10","key":"2023122116270407600_bib36","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3324\/haematol.2017.167726","article-title":"Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation","volume":"102","author":"Kanagal-Shamanna","year":"2017","journal-title":"Haematologica"},{"issue":"suppl 1","key":"2023122116270407600_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ijlh.12999","article-title":"Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia","volume":"41","author":"Galera","year":"2019","journal-title":"Int J Lab Hematol"},{"issue":"6","key":"2023122116270407600_bib38","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ajcp\/95.6.816","article-title":"B-cell precursors in normal pediatric bone marrow","volume":"95","author":"Caldwell","year":"1991","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2023122116270407600_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/ijlh.12073","article-title":"Bone marrow evaluation for pediatric patients","volume":"35","author":"Proytcheva","year":"2013","journal-title":"Int J Lab Hematol"},{"issue":"5","key":"2023122116270407600_bib40","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/cyto.b.21643","article-title":"Accurate quantification of fourteen normal bone marrow cell subsets in infants to the elderly by flow cytometry: bone marrow cell subset quantification by FCM","volume":"94","author":"Pont","year":"2018","journal-title":"Cytometry"},{"issue":"8","key":"2023122116270407600_bib41","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood.V98.8.2498","article-title":"Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry","volume":"98","author":"McKenna","year":"2001","journal-title":"Blood"},{"issue":"10","key":"2023122116270407600_bib42","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/jclinpath-2018-205168","article-title":"Automated enumeration of lymphoid and plasma cells in bone marrow to establish normal reference ranges","volume":"71","author":"Liang","year":"2018","journal-title":"J\u00a0Clin Pathol"},{"issue":"4","key":"2023122116270407600_bib43","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3324\/haematol.2014.116053","article-title":"Multifunctional human CD56low CD16low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients","volume":"100","author":"Stabile","year":"2015","journal-title":"Haematologica"},{"key":"2023122116270407600_bib44","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.2147\/IJGM.S375991","article-title":"Residual bone marrow T & NK-cells at diagnosis in pediatric pre-B-ALL: a case & control study","volume":"15","author":"Eldewi","year":"2022","journal-title":"Int J Gen Med"},{"issue":"1","key":"2023122116270407600_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/(SICI)1097-0320(19980215)34:1<22::AID-CYTO4>3.0.CO;2-G","article-title":"Age-related changes of lymphocyte subsets in normal bone marrow biopsies","volume":"34","author":"Rego","year":"1998","journal-title":"Cytometry"},{"issue":"5","key":"2023122116270407600_bib46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF01732876","article-title":"Phenotypic analysis of a large number of normal human bone marrow sample by flow cytometry","volume":"61","author":"Andreoni","year":"1990","journal-title":"Blut"},{"issue":"7","key":"2023122116270407600_bib47","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMsr1809937","article-title":"The \u2018All of Us\u2019 Research Program","volume":"381","author":"Denny","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"2023122116270407600_bib48","doi-asserted-by":"crossref","first-page":"S-235","DOI":"10.1016\/S0016-5085(21)01302-0","article-title":"Fr139 Gastrointestinal disease in patients with familial platelet disorder with associated myeloid malignancy","volume":"160","author":"Bhattacharya","year":"2021","journal-title":"Gastroenterology"},{"issue":"13","key":"2023122116270407600_bib49","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2012-04-422337","article-title":"Dysmegakaryopoiesis of FPD\/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression","volume":"120","author":"Bluteau","year":"2012","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/25\/2146\/2177507\/blood_bld-2023-019746-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/25\/2146\/2177507\/blood_bld-2023-019746-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T11:27:36Z","timestamp":1703158056000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/142\/25\/2146\/498043\/Natural-history-study-of-patients-with-familial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":49,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2023,12,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023019746","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]}}}